These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17311817)

  • 21. Preface.
    Verstovsek S
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):81-2. PubMed ID: 25189719
    [No Abstract]   [Full Text] [Related]  

  • 22. Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study.
    Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Guàrdia R; Marcos-Gragera R
    Leuk Lymphoma; 2015 Apr; 56(4):896-902. PubMed ID: 25058372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishing specific response criteria for MDS/MPN - Getting closer to reality?
    Villaume MT; Savona MR
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101170. PubMed ID: 32460975
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute myeloid leukemia and related conditions.
    Todd WM
    Hematol Oncol Clin North Am; 2002 Apr; 16(2):301-19. PubMed ID: 12094474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical applications of molecular haematology: flow cytometry in leukaemias and myelodysplastic syndromes.
    Dalal BI
    J Assoc Physicians India; 2007 Aug; 55():571-3. PubMed ID: 18019799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Value of Next-Generation Sequencing in the Screening and Evaluation of Hematologic Neoplasms in Clinical Practice.
    Northrup V; Maybank A; Carson N; Rahmeh T
    Am J Clin Pathol; 2020 Apr; 153(5):639-645. PubMed ID: 31875888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow Cytometry in Pediatric Hematopoietic Malignancies.
    Li J; Wertheim G; Paessler M; Pillai V
    Clin Lab Med; 2017 Dec; 37(4):879-893. PubMed ID: 29128074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative.
    Loscocco GG; Mannelli F; Guglielmelli P; Paoli C; Marone I; Cucci R; Coltro G; Sordi B; Albano F; Breccia M; De Stefano V; Finazzi G; Iurlo A; Martino B; Palandri F; Passamonti F; Siragusa S; Mannelli L; Fantoni D; Fazi P; Amadori S; Vignetti M; Barbui T; Vannucchi AM
    Am J Hematol; 2019 Sep; 94(9):E239-E242. PubMed ID: 31179561
    [No Abstract]   [Full Text] [Related]  

  • 29. Meningeal spread of blastic plasmacytoid dendritic cell neoplasm.
    Starck M; Zewen S; Eigler A; Wendtner CM
    Eur J Haematol; 2014 Aug; 93(2):175-6. PubMed ID: 24483771
    [No Abstract]   [Full Text] [Related]  

  • 30. The cytogenetics of haematological malignancies.
    Berger R
    Baillieres Clin Haematol; 1992 Oct; 5(4):791-814. PubMed ID: 1308165
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institution.
    Breccia M; Latagliata R; Mengarelli A; Biondo F; Mandelli F; Alimena G
    Haematologica; 2004 Jul; 89(7):866-8. PubMed ID: 15257942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias).
    Hasserjian RP; Kelley TW; Weinberg OK; Morgan EA; Fend F
    Am J Clin Pathol; 2019 Aug; 152(3):302-321. PubMed ID: 31263893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytogenetics in the study of malignant blood diseases].
    García JL; Hernández JM; Gutiérrez NC; Fernández P; Ríos A
    Sangre (Barc); 1996 Aug; 41(4):289-95. PubMed ID: 8984670
    [No Abstract]   [Full Text] [Related]  

  • 34. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
    Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
    Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of atypical chronic myeloid leukemia regarded as MDS with myeloproliferative features.
    Tohda S; Koyama N; Tanaka M; Kida Y; Murakami N; Nara N
    Acta Haematol; 1998; 100(4):191-4. PubMed ID: 9973641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor Survival.
    Sanford D; DiNardo CD; Tang G; Cortes JE; Verstovsek S; Jabbour E; Ravandi F; Kantarjian H; Garcia-Manero G
    Clin Lymphoma Myeloma Leuk; 2015 Sep; 15(9):556-62. PubMed ID: 26141213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochemistry and immunochemistry in hematologic diagnoses.
    Li CY; Yam LT
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):665-81. PubMed ID: 7961285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic eosinophilic leukemia with recurrent STAT5B N642H mutation-An entity with features of myelodysplastic syndrome/ myeloproliferative neoplasm overlap.
    Sreedharanunni S; Jamwal M; Balakrishnan A; Aravindan AV; Sharma R; Singh N; Rajpal S; Singla S; Khadwal AR; Ahluwalia J; Malhotra P; Das R
    Leuk Res; 2022 Jan; 112():106753. PubMed ID: 34856508
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibodies and immunohistochemical evaluation for the diagnosis of hematological malignancies: an overview.
    O'Malley DP; Orazi A
    Methods Mol Biol; 2007; 378():91-123. PubMed ID: 18605081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Issues in the pathology of the myelodysplastic syndromes.
    Kampmeier P; Anastasi J; Vardiman JW
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):501-22. PubMed ID: 1613003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.